Latest News in the pharma Industry

Research & Development

TCR2 bets on lead candidate with new cell therapy manufacturing facility

TCR2 bets on lead candidate with new cell therapy manufacturing facility

30 Mar 2021

The US facility in Rockville is expected to accelerate the company’s commercial-scale manufacturing timelines of gavo-cel

Read more 
China's Raybow Pharmaceuticals invests $15.8 million to expand US facility

China's Raybow Pharmaceuticals invests $15.8 million to expand US facility

23 Mar 2021

The company will triple its capacity and workforce at its North Carolina site to increase its global capabilities and reach

Read more 
Artificial intelligence a no-brainer for drug discovery

Artificial intelligence a no-brainer for drug discovery

16 Mar 2021

AI is helping pharma find the drug candidates with the greatest chance of success, according to experts who say therapeutic efficacy and cost reduction are the key dynamics

Read more 
Adaptive clinical trial success calls for flexible approach

Adaptive clinical trial success calls for flexible approach

15 Mar 2021

Adaptive clinical trials have accelerated COVID-19 vaccine development and could make drug R&D more efficient but running such studies is complex and challenging and sponsors need to prepare, say experts

Read more 
Clinical Development Success Rates and Contributing Factors 2011-2020: New Report from Informa Pharma Intelligence

Clinical Development Success Rates and Contributing Factors 2011-2020: New Report from Informa Pharma Intelligence

9 Mar 2021

Biologic products advance through clinical development with a higher success rate than traditional small molecules, this new analysis of clinical development success from Informa Pharma Intelligence, the Biotechnology Industry Organization and the...

Read more 
Lonza to develop and manufacture Ixogen's oncolytic virus

Lonza to develop and manufacture Ixogen's oncolytic virus

8 Mar 2021

PsiVac has generated compelling efficacy data in killing a broad range of tumour cells, including head and neck, bladder, liver, pancreatic and ovarian

Read more 
CPhI Monthly Podcast: Decentralised Clinical Trial Design - Collecting Real World Data in a Remote Setting

CPhI Monthly Podcast: Decentralised Clinical Trial Design - Collecting Real World Data in a Remote Setting

4 Mar 2021

In this podcast interview with Fabien Du Fraisse and Deepu Joseph at Quanticate, we delve into the trend of decentralising clinical trials 

Read more 
Regis completes expansion of US-based API development facility

Regis completes expansion of US-based API development facility

17 Feb 2021

The CDMO doubles its capacity to take on new development projects

Read more 
Lonza boosts solid form services for small molecule APIs

Lonza boosts solid form services for small molecule APIs

16 Feb 2021

The expanded and refined first-in-human services have been designed to meet the early-stage molecule development of small biopharma players

Read more 
Phlow secures $20 million to advance manufacturing initiatives in the US

Phlow secures $20 million to advance manufacturing initiatives in the US

16 Feb 2021

The company seeks to actively accelerate US manufacturing for medicines at risk of shortage, including those for COVID-19 pandemic response

Read more 
Quotient Sciences expands service portfolio with Arcinova acquisition

Quotient Sciences expands service portfolio with Arcinova acquisition

9 Feb 2021

The acquisition will extend the 12-month drug development timeline savings already delivered by Quotient’s flagship platform Translational Pharmaceutics

Read more 
Catalent secures Trizell cell therapy development and manufacturing contract

Catalent secures Trizell cell therapy development and manufacturing contract

8 Feb 2021

The agreement allows the CDMO to "stay on the forefront of emerging indications and cell types"

Read more